Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?”
Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes.
AMA J Ethics. 2022;24(2):E111-119. doi:
10.1001/amajethics.2022.111.
Carmen Black, MD, Emma Lo, MD, and Keith Gallagher, MD
Violence perpetrated against unarmed patients is common in health care, and evidence-based safety measures are needed to acknowledge and eradicate clinical violence.
AMA J Ethics. 2022;24(3):E218-225. doi:
10.1001/amajethics.2022.218.
Dr Natalie Bonfine joins Ethics Talk to discuss her article, coauthored with Dr Mark R. Munetz: “Crisis Intervention Team Program Leadership Must Include Psychiatrists.”
Dr Amy Watson joins Ethics Talk to discuss how crisis intervention teams can motivate efficiency and equity in tactical responses to 911 calls and what community mental health intervention might look like when we think beyond the limits of law enforcement response.
The FDA's decision to put a black-box warning on antidepressant labels may be misleading because it implies that antidepressants have definitely been found to increase suicidality in adolescents, when in fact there is merely a lack of clear evidence about their safety.
Physicians are obligated to inform patients involved in a clinical trial that there is a chance of receiving a placebo, which can result in a deterioration of a medical condition.